Who Guidelines for the Prevention, Care and Treatment of Persons With Chronic Hepatitis B Infection / World Health Organization.
Contributor(s): World Health Organization. Global Hepatitis Programme [issuing body.].
Geneva, Switzerland : World Health Organization, c2015Edition: March 2015.Description: xxx, 134 pages ; 21 cm.ISBN: 9789241549059.Subject(s): Chronic diseases | Hepatitis B -- Epidemiology | Hepatitis B -- Patients -- Care | Hepatitis B -- TreatmentGenre/Form: Print books.Summary: These are the first World Health Organization (WHO) guidelines for the prevention, care and treatment of persons living with chronic hepatitis B (CHB) infection, and complement similar recently published guidance by WHO on the prevention, care and treatment of infection due to the hepatitis C virus (HCV). The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2-11 years) for first- and second-line treatment. Recommendations for the treatment of HBV/HIV-coinfected persons are based on the WHO 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which will be updated in 2015. These recommendations provide opportunities to save lives, improve clinical outcomes of persons living with CHB, reduce HBV incidence and transmission, and stigma due to disease, but they also pose practical challenges to policymakers and implementers in low- and middle-income countries. --Provided by publisher.Current location | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|
On Shelf | RC848.H44 G853 2015 (Browse shelf) | Available | AU0000000003821 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
RC848.H425 T56 2015 Hepatitis C : a complete guide for patients and families / | RC848.H43 S26 2015 The Sanford Guide to viral hepatitis therapy | RC848 .H44 2014 Therapy of Hepatitis B virus infections - potential and limitations 12 tables | RC848.H44 G853 2015 Who Guidelines for the Prevention, Care and Treatment of Persons With Chronic Hepatitis B Infection / | RC848.H44 G854 2014 Guidelines for the screening, care and treatment of persons with hepatitis C infection. | RC858 .P35 2017 Pancreatitis : medical and surgical management / | RC860 .R3813 2017 Health through inner body cleansing : the famous F.X. Mayr intestinal therapy from Europe / |
Includes bibliographical references and index.
These are the first World Health Organization (WHO) guidelines for the prevention, care and treatment of persons living with chronic hepatitis B (CHB) infection, and complement similar recently published guidance by WHO on the prevention, care and treatment of infection due to the hepatitis C virus (HCV). The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2-11 years) for first- and second-line treatment. Recommendations for the treatment of HBV/HIV-coinfected persons are based on the WHO 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which will be updated in 2015. These recommendations provide opportunities to save lives, improve clinical outcomes of persons living with CHB, reduce HBV incidence and transmission, and stigma due to disease, but they also pose practical challenges to policymakers and implementers in low- and middle-income countries. --Provided by publisher.